SRS Medical Systems
SRS Medical Systems is a private medical device company that develops and sells non-invasive diagnostic and therapeutic devices for male lower urinary tract symptoms and BPH, including the UroCuff pressure-flow system, The Spanner temporary prostatic stent, and the UroReport.com clinical decision support platform, sold directly to urology practices and hospitals in the United States.
- Company typePrivate
- Founded1991
- HeadquartersFeeding Hills, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What SRS Medical Systems does
SRS Medical Systems is a privately-held medical device company founded in 1991 and headquartered in Chelmsford, Massachusetts, that develops and commercializes diagnostic and therapeutic devices for male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). The company's portfolio centers on non-invasive bladder function assessment, anchored by The UroCuff Test — a patented penile-cuff system that measures bladder pressure during voiding without catheterization — and complemented by the EasyPro 4 12-channel urodynamics system, the EasyFlo standalone uroflow device, and the VP Test handheld urodynamics tool for catheterized patients. On the therapeutic side, The Spanner temporary prostatic stent provides an FDA-approved alternative to Foley catheters for men with bladder outlet obstruction.
The company's proprietary technology stack includes patented components such as the LPD-3D electronic leak-point detector, T-DOC air-charged catheters, and The Spanner's proximal-balloon stent design, all protected by issued patents and FDA clearances. The UroReport.com platform — a HITRUST CSF-certified, Azure-hosted clinical decision support system — integrates UroCuff diagnostic output with treatment recommendations, representing the company's pivot toward recurring software revenue and creating workflow dependency within urology practices. The Spanner insertion procedure has a dedicated CPT code (53855), simplifying reimbursement.
Commercially, SRS Medical sells capital equipment (UroCuff CT3000 Pro, EasyPro 4) plus recurring disposables (cuffs, catheters, leak-point sensors, stents) through a direct field-sales force targeting urology practices and hospital urology departments across the United States. The company reports 103 urology practice customers and over 50,680 patients tested with the UroCuff system, with peer-reviewed validation from institutions including Mayo Clinic and Palmerston North Hospital. Revenue is undisclosed; the company is led by CEO Lee Brody (since 2012, previously COO), EVP of New Business Development David Mahoney, and VP of Sales & Marketing Chris Ernster, with prior commercial experience at Boston Scientific, Medtronic, and Bard.
SRS Medical Systems firmographics
Firmographics- Name
- SRS Medical Systems
- Legal name
- SRS Medical Systems
- Website
- https://srsmedical.com
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- SRS Medical Systems is a private medical device company that develops and sells non-invasive diagnostic and therapeutic devices for male lower urinary tract symptoms and BPH, including the UroCuff pressure-flow system, The Spanner temporary prostatic stent, and the UroReport.com clinical decision support platform, sold directly to urology practices and hospitals in the United States.
- Ownership category
- akta.pro rank
SRS Medical Systems industry classification
Industry- Product category
- Urological Diagnostic and Therapeutic Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Neurourology & Voiding Dysfunction (HLAKAOAI)
- akta.pro secondary industry
- Continence Care Products (Adult Incontinence Pads/Briefs, Underpads, External Collectors) (HLAHALAH)
Keywords
Where SRS Medical Systems is headquartered
LocationHeadquarters
- HQ city
- Feeding Hills
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
SRS Medical Systems business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Diagnostic Devices: Sale of diagnostic equipment including UroCuff Test system, EasyPro 4 Urodynamics System, and EasyFlo uroflow devices. These are capital equipment purchases for urology practices.
- Therapeutic Devices: Sale of The Spanner Temporary Prostatic Stent - a therapeutic device for men with bladder outlet obstruction. Available in 6 sizes (4-9 cm).
- Disposable Supplies: Recurring revenue from disposable products including UroCuff disposable cuffs, urodynamics catheters, T-DOC air-charged catheters, leak-point detectors, and Spanner stents.
- Software/SaaS: UroReport.com clinical decision support software platform for urology practices. HITRUST certified, hosted on Microsoft Azure.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
SRS Medical Systems product offering
Product offeringCore offering
SRS Medical Systems manufactures and sells medical devices for the diagnosis of voiding disorders and conservative treatment of urinary incontinence in male LUTS/BPH patients. Its portfolio combines non-invasive bladder function diagnostics (UroCuff Test, VP Test, EasyPro 4, EasyFlo), an FDA-approved temporary prostatic stent (The Spanner), proprietary disposable supplies, and the UroReport.com clinical decision support software, sold primarily to urology practices and hospital urology departments in North America.
Product overview
SRS Medical Systems offers a unified portfolio of urologic diagnostic and therapeutic products centered on bladder function assessment for male LUTS patients. The core offering includes The UroCuff Test (non-invasive pressure-flow diagnostics), The Spanner Stent (temporary prostatic stent as an alternative to Foley catheters), and The VP Test (handheld urodynamics for catheterized patients), all supported by UroReport.com—a HITRUST-certified clinical decision support software platform that integrates with UroCuff data to guide treatment decisions. The portfolio is complemented by the EasyPro 4 Urodynamics System, EasyFlo uroflow device, and a range of proprietary disposable components including LPD-3D leak-point detectors and T-DOC air-charged catheters.
Differentiator
Problem solved
Functional benefit
Brands
- UroReport.com: Secure web-based clinical decision support software platform that integrates with UroCuff reports for data-driven treatment decisions. HITRUST certified, hosted on Microsoft Azure.
- UroCuff
- The Spanner Stent
- The VP Test
- EasyPro 4 Urodynamics System
- EasyFlo Uroflow
Products and services
- The UroCuff Test Non-invasive pressure-flow diagnostic test for male LUTS that measures bladder pressure during voiding using a proprietary penile cuff method (CT3000 Pro device), enabling urologists to differentiate bladder outlet obstruction from poor bladder contractility and optimize BPH care.
- The Spanner Stent FDA-approved temporary prostatic stent with proximal balloon design (6 sizes, 4-9 cm) that maintains urine flow and allows voluntary voiding for men with bladder outlet obstruction, serving as a catheter-replacement alternative covered under CPT code 53855.
- The VP Test Single-channel handheld urodynamics device that measures bladder function without disturbing a Foley catheter in place by using the catheter balloon to measure changes in vesical pressure during filling and emptying stages, optimizing catheter removal decisions.
- UroReport.com Secure HITRUST-certified, Microsoft Azure-hosted web-based clinical decision support software platform that integrates with UroCuff reports to enable data-driven, personalized clinical treatment decisions for male LUTS management.
- EasyPro 4 Urodynamics System 12-channel urodynamics system with touch-screen interface, electronic leak-point detection, custom rolling stand for in-office portability, and air-charged catheter compatibility for comprehensive bladder function assessment.
- EasyFlo Stand-alone Uroflow Stand-alone uroflow system for quick in-office screening of voiding dysfunction with one-touch operation, automatic test start/end, and Liverpool Nomogram comparison.
- LPD-3D Disposable Electronic Leak-Point Detector Patented disposable electronic sensor that automatically measures leak-point pressure by detecting the first drop of urine, replacing hand-switches and manual event markers during urodynamics.
- T-DOC Air-Charged Catheters Proprietary pressure-sensing urodynamic catheters using air-charged technology with plug-and-play pressure readings, circumferential pressure sensing, and no requirement for external transducers or water-filled lines.
- The Surveyor Urethral Measurement Device Urethral measurement device used to assess the length of the urethra from the bladder neck to the external sphincter in order to select the appropriately sized Spanner stent.
Quantifiable outcome
- 87% positive predictive value for TURP outcomes in men categorized as having bladder outlet obstruction by UroCuff
- +7 more outcomes
Companies that use SRS Medical Systems
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
SRS Medical Systems technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
SRS Medical Systems partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights6 records
SRS Medical Systems competitors and assessment
Company assessmentBroad incumbents
- Medtronic: Medtronic's Pelvic Health business offers sacral neuromodulation (InterStim) and tibial neuromodulation for urological conditions, serving the same urology specialty customer base as SRS with a broader portfolio of incontinence and voiding dysfunction therapies.
- Teleflex: Teleflex manufactures urological catheters and specialty products serving the same catheter-dependent patient population targeted by The Spanner, with broader product breadth and established hospital distribution channels.
- Boston Scientific: Boston Scientific operates a significant urology and pelvic health franchise with products spanning BPH treatment, urodynamics, and stone management, competing with SRS across multiple categories while leveraging far greater scale and sales coverage.
- BD (Bard): BD's Bard urology franchise provides an extensive range of urological products including catheters, drainage systems, and surgical supplies that compete with SRS's catheter alternative offerings and broader urology consumables.
Direct peers
- Verathon: Verathon manufactures portable ultrasound bladder scanners and is cited alongside SRS Medical as a leading manufacturer in the urology diagnostics space, targeting the same urology practice customers with complementary (rather than identical) bladder assessment technology.
- Hollister Incorporated: Hollister is a major continence care products manufacturer offering catheters and related urological supplies, directly competing with SRS in the catheter-dependent patient segment that The Spanner targets as a catheter alternative.
- CooperSurgical: CooperSurgical offers women's health, fertility, and urology/pelvic health diagnostic devices, serving overlapping specialty practice customers as SRS Medical in the urodiagnostics space with a broader reproductive health portfolio.
- Coloplast: Coloplast is a major continence care and urology products company offering catheters and catheter alternatives that compete with The Spanner in addressing male bladder outlet obstruction and catheter-dependent patient needs.
- Laborie Medical Technologies: Laborie is a leading global manufacturer of urodynamic diagnostics and pelvic health devices, directly competing with SRS Medical in urodynamics equipment and serving the same urology practice customer base with similar capital equipment and disposable supply business models.
Emerging players
- Axonics Modulation Technologies: Axonics is a focused medical device company developing sacral neuromodulation systems for urinary and bowel dysfunction, targeting the same urology specialty practices with an alternative therapeutic approach to voiding disorders.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
SRS Medical Systems social profiles
Digital presenceSRS Medical Systems compliance and trust
Trust signalCompliance1 record
SRS Medical Systems financial estimates
Financial estimateRevenue estimate
Valuation estimate
SRS Medical Systems leadership team
Management profileNumber of profiles
Profiles3 records
SRS Medical Systems funding detail
Funding detailFunding overview
Funding rounds4 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SRS Medical Systems M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SRS Medical Systems
What does SRS Medical Systems do?
SRS Medical Systems manufactures and sells medical devices for the diagnosis of voiding disorders and conservative treatment of urinary incontinence in male LUTS/BPH patients. Its portfolio combines non-invasive bladder function diagnostics (UroCuff Test, VP Test, EasyPro 4, EasyFlo), an FDA-approved temporary prostatic stent (The Spanner), proprietary disposable supplies, and the UroReport.com clinical decision support software, sold primarily to urology practices and hospital urology departments in North America.
Is SRS Medical Systems a public or private company?
SRS Medical Systems is a private company. It is classified as venture growth investor backed and is currently operating.
When was SRS Medical Systems founded?
SRS Medical Systems was founded in 1991. It employs 11 to 50 people.
Where is SRS Medical Systems based?
SRS Medical Systems is headquartered in Feeding Hills, United States, in the North America region.
How does SRS Medical Systems make money?
Four revenue lines are on record. Diagnostic Devices are the primary driver. The others are therapeutic Devices, disposable Supplies and software/SaaS.
Who are SRS Medical Systems's main competitors?
Broad incumbents on record are Medtronic, Teleflex, Boston Scientific and BD (Bard). Direct peers are Verathon, Hollister Incorporated, CooperSurgical, Coloplast and Laborie Medical Technologies. Axonics Modulation Technologies is listed as an emerging player.
Does SRS Medical Systems have an API?
No public API is recorded for SRS Medical Systems.
What industry is SRS Medical Systems in?
SRS Medical Systems's product category is Urological Diagnostic and Therapeutic Medical Devices. Its primary akta.pro industry code is HLAKAOAI, Neurourology & Voiding Dysfunction, with a secondary code of HLAHALAH, Continence Care Products (Adult Incontinence Pads/Briefs, Underpads, External Collectors). Its NAICS code is 339113 and its SIC code is 3841.